Other studies in melanoma (Eberle et al., 1997; Eberle et al., 2002), B-cell malignancies (Thompson et al., 2021), hypopharynx cancer (Xu et al., 2013), pancreatic cancer (Ma et al., 2019), and endometrioid endometrial cancer (Lomnytska et al., 2012) have indicated tumor promoter roles for the eIF4A1 protein. Here, EIF4A1 is linked to neoplasm.